Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1
2024 · Nature Communications · 53 citations
https://doi.org/10.1038/s41467-023-44466-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
238
Citations
6
h-index
6
i10-index
Zilong Xu is an academic researcher from Xiamen University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Adenosine and Purinergic Signaling & Amino Acid Enzymes and Metabolism. The author has an h-index of 6, co-authored 13 publications.
ORCID: 0009-0001-5619-5834Click to start Chat